Home » Topics » Disease categories and therapies » Urology

Urology
RSS

N-Alkylated saccharins from Merck & Co. with potential in BPH therapy

April 2, 1998

FDA approves DDAVP tablets for nocturnal enuresis in children

April 1, 1998

New vasopressin antagonist from JT with aquaretic effects in animals

April 1, 1998

Detrol approved by FDA for overactive bladder

March 30, 1998

Synaptic licenses technology for BPH treatment to Glaxo Wellcome

March 25, 1998

Genetic basis for congenital kidney disease pinpointed by BioStratum scientists

March 23, 1998

Taiwan researchers identify lead potassium channel opener selective for bladder

March 18, 1998

Use of aspirin to prevent preeclampsia should be discontinued, NIH researchers say

March 13, 1998

Detrusitol launched in U.K. and Germany

March 11, 1998

New potassium channel activators from American Home

March 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...